New Product: Trisenox (arsenic trioxide) 2mg/ml Concentration for Solution for Infusion

This is a new strength of Trisenox licensed for same indications as 1mg/ml infusion i.e. induction of remission and consolidation of newly diagnosed acute promyelocytic leukaemia and relapsed/refractory acute promyelocytic leukaemia, alongside specific considerations.

electronic Medicines compendium